You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 8, April 27, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Review
 •Gastrointestinal Diseases
 •Alert me on articles by topic

Treatment of Helicobacter pylori Infection

Julio A. Salcedo, MD; Firas Al-Kawas, MD

Arch Intern Med. 1998;158:842-851.

Since acceptance of the association between Helicobacter pylori and peptic ulcer disease, eradication of H pylori has become the standard of care in the treatment of peptic ulcer disease. Unfortunately, eradication therapy is no easy task, especially when one is faced with a myriad of drug combinations with varying degrees of efficacy and tolerability. The following is a review of the literature regarding the drugs and drug combinations used to eradicate H pylori and their effectiveness both as single agents and in combination.


From the Department of Gastroenterology, Georgetown University Medical Center, Washington, DC.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Posttreatment Follow-Up of Helicobacter pylori Infection Using a Stool Antigen Immunoassay
Roth et al.
CVI 2001;8:718-723.
ABSTRACT | FULL TEXT  

Treating Helicobacter pylori
Howden et al.
Arch Intern Med 1998;158:2396-2398.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.